Oral Solid Dose CDMOs

Morepen Laboratories Limited

India

Morepen Laboratories Limited is an Indian pharmaceutical company with 40+ years of expertise in API and formulation manufacturing. The company has recently secured an INR 825 crore (approx. USD 100M) multi-year global CDMO mandate, marking a significant expansion into contract manufacturing. Morepen operates a scientifically integrated complex in Baddi with 10 dedicated manufacturing plants. The company exports to 80+ countries and holds FDA, WHO GMP, and EU GMP certifications. Known for the consumer brand Dr. Morepen (home health devices).

NextPharma

Finland

NextPharma is a European pharmaceutical CDMO headquartered in Finland with 10 manufacturing sites across Europe. The company provides pharmaceutical development, clinical trial supply, commercial manufacturing, packaging, and analytical services across a wide range of dosage forms including solids, semi-solids, liquids, softgel capsules, ophthalmics, modified release products, and specialist areas such as hormones, cephalosporins, penicillins, and narcotics.

Nifty Labs Pvt. Ltd.

India

Nifty Labs Pvt. Ltd. is an Indian API and advanced intermediate manufacturer based in Hyderabad, established in 2005. The company operates USFDA, EU GMP, KFDA, and PMDA-approved manufacturing facilities. Through its wholly-owned subsidiary Nifty Pharma, it also manufactures semi-finished dosage forms (pellets with various release profiles). The facility has four production blocks with process equipment handling 0.1L to 7kL batch sizes.

NOVELTY PHARMA GDD SA

Switzerland

Novelty Pharma GDD SA is a Swiss company based in Cadempino, Lugano, specializing in effervescent pharmaceutical tablet manufacturing for over 25 years. The company develops pharmaceutical products, dietary supplements, and cosmetic products in effervescent form. Novelty Pharma offers both tailor-made custom manufacturing and ready-to-buy product ranges, with proprietary technologies including UNISTACK (partial granulation), UCT (Ultra Compressed Technology), and EFFERGIZE for complex molecule formulation. The company has expanded into India with a development lab and manufacturing site.

Ofichem Group

Netherlands

Ofichem Group is a family-owned European CDMO and pharmaceutical supplier founded in 1975, headquartered in Ter Apel, Netherlands. The company provides end-to-end services from drug substance (API) development through finished drug product manufacturing, including sourcing and distribution. Ofichem has recently expanded through acquisitions of Meribel Pharma Solutions' Uppsala site (early-phase development, ADCs, oligonucleotides, PROTACs) and Avivia (formulation development).

O.F.I. Officina Farmaceutica Italiana

Italy

O.F.I. Officina Farmaceutica Italiana is an Italian contract development and manufacturing company established in 1946, specializing in food supplements, medical devices, and dermo-cosmetic products. The company provides full-service contract manufacturing from idea generation to production, with capabilities in tablets, capsules, creams, gels, probiotics, and sterile processes. OFI holds ISO certifications including ISO 13485 (medical devices) and is FDA approved and Halal certified.

One Pharma S.A.

Greece

One Pharma S.A. is a Greek pharmaceutical company that became a fully independent CMO/CDMO in 2019 after a major refurbishment of its production facilities in 2013. The company offers contract manufacturing services with an annual production capacity per shift of 800 million tablets and 5,000 additional units.

OneSource Specialty Pharma Limited

India

OneSource Specialty Pharma Limited (formerly Stelis Biopharma Limited) is India's first specialty pharma pure-play CDMO, offering multimodal end-to-end capabilities across drug-device combinations, complex sterile injectables, biologics, and soft gelatin capsules. The company operates five state-of-the-art facilities in Bengaluru with 35 approved ANDAs and 19 commercialized drug products in the US market.

Osmopharm S.A.

Switzerland

Osmopharm S.A. is a Swiss pharmaceutical company founded in 1994 in Southern Switzerland (near Lugano), specializing in modified release oral drug delivery systems. It is one of the worldwide leaders in contract manufacturing of modified release oral solid dosage forms. The facility covers approximately 6,000 sqm and serves over 100 pharmaceutical customers. Authorized by Swissmedic under current GMP requirements.

Pagari PharmaTech, INC.

India

Pagari PharmaTech, INC. is a U.S.-based CDMO offering concept-to-commercialization services including Research and Development, Analytical Services, Technology Transfer, and Manufacturing Services for Solid and Liquid Oral Dosage Forms as well as OTC and Prescription (Rx) Drug Products. The company adheres to FDA, EMA, and ICH guidelines with support for IND, NDA, ANDA, and 505(b)(2) submissions. Small company (2-10 employees per LinkedIn), based in India with U.S. manufacturing services.

PharmaBlock Group

China

PharmaBlock Group is the parent entity of PharmaBlock (Stock code: 300725.SZSE), a leading CRDMO with 2,300 employees and 700+ global partners across 7 sites. The group provides building blocks, chemistry research, drug substance CDMO, and drug product CDMO services. It holds an EcoVadis Silver Medal for sustainability. Note: this is the same company as PharmaBlock (duplicate entry).

Pharmaghreb

Tunisia

Pharmaghreb is the first private pharmaceutical industry created in Tunisia, founded in 1985. The company manufactures pharmaceutical products including tablets, creams, gels, and parapharmaceutical products. It holds ISO 9001:2015 and ISO 14001:2015 certifications and has expanded internationally. In 2024, BioGeneric Pharma acquired a majority stake in Pharmaghreb.

Pharmalink S.L

Spain

Pharmalink S.L. (operating as STE Pharmaceuticals) is a Barcelona-based company focused on the development and manufacture of medical devices and food supplements according to pharmaceutical quality standards. The company offers turnkey product development including pump sprays, BoV sprays, syrups, oral sprays, tablets, single dose vials, and cosmetic formulations. It has 40+ years of experience in the pharmaceutical sector.

PLD Pharma Services

United States

PLD Pharma Services (formerly Avema Pharma Solutions) is the CDMO division of PL Developments, providing development, manufacturing, and packaging for liquid and solid dose delivery systems based on small molecule APIs. Over three decades of expertise spanning OTC, Rx, diagnostics, and dietary supplements. Offers formulation development, method development & validation, regulatory expertise, and packaging. Recently expanded into pharmaceutical-grade gummy manufacturing in Copaigue, NY.

Praxis Packaging Solutions

United States

Praxis Packaging Solutions is a U.S.-based contract packaging company in Grand Rapids, Michigan, providing primary and secondary packaging services for pharmaceutical, OTC, and healthcare products. Their capabilities include solid dose packaging (bottling, blister packaging), liquid/cream/paste filling for tubes, bottles, jars, and flexible packaging, and secondary packaging (labeling, cartoning, bundling, kitting). They operate FDA-registered, DEA-licensed (Schedule III-V), and cGMP-compliant facilities. FDA-registered with 2 FEI numbers with 4 inspections (3 NAI, 1 VAI). While primarily a packager, they perform contract manufacturing for finished dosage forms.

Procaps Group

Brazil

Procaps Group (now operating as Sofgen Pharma) is a leading integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions, with a strong focus on softgel technology. The company operates 8 manufacturing facilities across North, Central, and South America with CDMO businesses including Softigel, Sofgen Pharmaceuticals, and Softcaps Brazil. Procaps has direct presence in 13 countries and exports to over 50 markets.

Quality Chemical Laboratories (QCL)

United States

Quality Chemical Laboratories (QCL) is a US-based CDMO located in Wilmington, North Carolina, specializing in comprehensive analytical testing, formulation development, and GMP clinical manufacturing. The company offers API synthesis, method development, taste masking, enteric coating, tablet film coating, and controlled/immediate release formulation development. QCL is FDA-registered for analysis, API manufacture, drug product manufacturing, and packaging.

Quotient Sciences

United Kingdom

Quotient Sciences is a UK-headquartered pharmaceutical CRDMO (contract research, development, and manufacturing organization) specializing in small molecule and synthetic peptide drug product development and manufacturing. They offer integrated formulation development, clinical manufacturing, and commercial production, with their proprietary Translational Pharmaceutics approach integrating clinical activities with real-time cGMP manufacturing. They have facilities in the US and UK, with capabilities including HPAPI manufacturing, sterile fill/finish, and oral solid dose.

Raritan Pharmaceuticals, Inc.

United States

Raritan Pharmaceuticals is a US-based contract manufacturer specializing in OTC pharmaceuticals, consumer products, and high-end cosmetics. They develop, manufacture, and market generic OTC medicines and niche OTC brands. Their expertise includes chewable tablets, fast-dissolving tablets, powders, capsules, specialty liquids, gels, ointments, creams, and film-delivery systems. They operate from East Brunswick, NJ with FDA-registered manufacturing facilities. Notable regulatory history includes multiple recalls (15 Class II) and OAI inspection.

Recipharm AB

Sweden

Rechon Life Science AB is a subsidiary/entity within the Recipharm group, the global CDMO headquartered in Stockholm, Sweden. This entry represents the same Recipharm organization (same website: recipharm.com) with its extensive global manufacturing footprint of 15+ FDA-registered FEI numbers and 52 FDA inspections. The Perplexity research confirms Recipharm's specialization in oral solid dose, inhalation, sterile manufacturing, and HPAPI capabilities. Rechon may represent a specific Recipharm site or legacy entity. Duplicate of Recipharm AB entry -- capabilities are identical.

REMEDICA LTD

Cyprus

REMEDICA is a Cyprus-based pharmaceutical manufacturer that has been operating for over four decades, distributing products in more than 160 countries. They manufacture generics across multiple therapeutic areas and dosage forms (solid oral dose, liquids, semi-solids, sterile injectables) and offer contract manufacturing (CMO/CDMO) services. They have long-standing relationships with NGOs (UNICEF, WHO, UNRWA). They focus on B2B partnerships, own-brand commercialization (Cyprus, Eastern EU, Asia, Middle East, Africa, LATAM), and NGO supply.

Renejix Pharma Solutions

United States

Renejix Pharma Solutions (operating as HyCON Labs) is a US-based CDMO specializing in small molecule oral dosage form development and multi-modality manufacturing. The company offers end-to-end services from preformulation through commercial manufacturing, with 14+ technologies, 300+ pieces of equipment, 350+ employees, and 2+ facilities. They serve as a single-partner CDMO across all development stages.

Rioja Nature Pharma

Spain

Rioja Nature Pharma is a Spanish CDMO specializing in nutraceuticals and food supplements, founded in 2009 in Calahorra, La Rioja. The company manufactures softgels, capsules, tablets, powders/sachets, and liquid products under contract for third-party brands. While described as a CDMO on industry platforms, their core focus is food supplement and nutraceutical contract manufacturing rather than pharmaceutical drug manufacturing.

SCN BestCo

United States

SCN BestCo is a contract manufacturer of innovative pharmaceutical dosage forms for OTC drugs, vitamins, and dietary supplements. It specializes in gummy, soft chew, coated chew, and lozenge dosage forms and operates as a contract manufacturer of consumer healthcare products since 1976.

Serán BioScience

United States

Seran BioScience is a US-based CDMO headquartered in Bend, Oregon, recognized as a world leader in drug delivery and formulation development. The company provides comprehensive drug development and clinical/commercial manufacturing services, specializing in spray drying and particle engineering, preformulation, dosage form development, and cGMP manufacturing. Seran recently secured $200M+ from Bain Capital to build a new 100,000 sqft commercial manufacturing facility for non-sterile oral solid dose pharmaceuticals.

SIDEFARMA

Portugal

SIDEFARMA is a Portuguese CMO with over 45 years of experience, specialized in the manufacture of small and medium-size batches of solid dosage forms (coated tablets, tablets, capsules), semi-solids (creams, gels, ointments), and liquid pharmaceuticals. The company provides contract manufacturing, contract packaging, and contract development services following European quality standards, while also commercializing its own branded pharmaceutical products.

Siegfried Group

China

Siegfried Group is a leading global CDMO with 150+ years of pharmaceutical and chemical heritage, operating 13 production sites across Switzerland, Germany, Spain, France, Malta, the USA, and China. The company provides integrated services from early-phase API development through commercial-scale drug substance and drug product manufacturing, including exclusive synthesis, generic APIs, controlled substances, HPAPI handling, sterile formulations, and viral vector manufacturing through subsidiary DINAMIQS. In January 2026, Siegfried announced acquisition of additional US-based small molecule drug substance capacity.

SmaBio Labs

United States

SmaBio Labs is a USA-based CDMO located in Research Triangle Park, North Carolina, delivering end-to-end drug development solutions from molecule discovery to market launch. They specialize in Chemistry Manufacturing and Control (CMC) services for small molecules, peptides, biologics, and complex APIs. Their capabilities include analytical services (IND/ANDA support, method development and validation, ICH stability testing, HPLC/UPLC, LC-MS, ICP-MS, NMR, XRPD), drug discovery and process development, API manufacturing (kg-scale cGMP), product development (formulation for oral solid dose, injectables, lyophilized products), and clinical trial material manufacturing (Phase I-III). FDA registered for analytical services. They support HPAPI compounds up to OEB 5.

Special Product’s Line – CDMO Services

Italy

Special Product's Line (SPL) is an Italian CDMO founded in 1978, specializing in the production of non-sterile pharmaceutical products. The company operates a 50,000 sqm state-of-the-art facility with over 500 employees, serving more than 60 international pharmaceutical companies. SPL offers full-service CDMO capabilities from development to production and registration across a wide range of dosage forms including tablets, capsules, powders, oral liquids, creams, suppositories, ovules, and softgel capsules.

Sunsho Pharmaceutical Co., Ltd.

Japan

Sunsho Pharmaceutical Co., Ltd. is Japan's leading contract manufacturing pharmaceutical company, operating as a CDMO across three business verticals: health food (supplements), new applications (flavor capsules), and pharmaceuticals (generic drugs). The company specializes in capsule and formulation technologies, with the Nanryo Factory being one of the largest soft capsule manufacturing plants in Japan.

Swiss Garnier Life Sciences

India

Swiss Garnier Life Sciences is an Indian contract manufacturing organization operating multiple pharmaceutical manufacturing plants. The company produces tablets (coated and uncoated), capsules, sachets, liquids, and ointments across four manufacturing facilities. Plant 1 (Mehatpur, Himachal Pradesh) handles pharmaceutical products with 1,680 million units capacity, while Plant 2 focuses on nutraceutical and Ayush products with 2,520 million units capacity. The company achieved DIGEMID Peru certification with zero observations in September 2025.

Swiss Parenterals Limited

India

Swiss Parenterals Limited is an Indian pharmaceutical manufacturing company producing tablets, capsules, injections, and sterile eye preparations. The company has integrated with Eris Lifesciences Limited and operates as a CDMO/CMO partner. The company manufactures across a wide range of dosage forms and technologies, including parenteral drug products and oral solid dosage forms.

Synokem Pharmaceuticals Ltd

India

Synokem Pharmaceuticals Ltd is one of India's largest CDMOs, backed by TA Associates investment (2023). The company specializes in contract development and manufacturing, ethical marketing, and pharmaceutical exports. Synokem acquired Nitin Lifesciences Ltd and Parabolic Drugs Ltd to expand API production capacity. The company recently launched a modernized cephalosporin injectable manufacturing block for commercial production. Synokem's website is currently suspended but the company remains operational and expanding.

Tedor Pharma Inc

United States

Tedor Pharma is a US-based CDMO with 20+ years of experience specializing in solid oral dosage forms. Located in Cumberland, Rhode Island, they provide end-to-end outsourcing from IND/NDA/ANDA through commercial manufacture. Services include formulation development, clinical trial manufacturing (including placebo), commercial GMP manufacturing at various scales, analytical services (characterization, testing, development, QA), and clinical supply chain management. FDA-registered and inspected (5 inspections, all VAI), DEA-licensed for controlled substances Schedules II-V. They have 2 FDA-approved products (tablets, oral route). The company announced a recapitalization and new management.

Tekro Lab

Czechia

Czech pharmaceutical CRO and CDMO specializing in veterinary pharmaceuticals and animal health. Offers GMP-certified contract manufacturing of solid dosage forms (premixes, pellets, tablets) with various active substances including penicillins, tetracyclines, and potentiated sulphonamides. Also provides contract research (preclinical studies), pharmacovigilance services, and regulatory affairs for veterinary medicinal products. Over 30 years of experience in the pharma industry.

Thompson & Capper Ltd (HBI Thompson & Capper)

United Kingdom

UK-based contract manufacturer specializing in nutritional supplements and pharmaceutical tablets. Part of HBI (Healthy Business International) group, now joined Ourvita Group. Tailor-makes vitamins, minerals, health supplements, and specialty tablets. Offers a wide range of dosage formats including tablets, chewies, melts, effervescents, powders, hard gel capsules, soft gel capsules, and liquids. Handles 4,000+ raw materials. FDA-registered. Focused on nutritional and supplement contract manufacturing rather than prescription pharmaceutical manufacturing.

Titan Laboratories Pvt Ltd

India

Titan Laboratories Pvt Ltd is an integrated Indian pharmaceutical company and the first Indian pellet company to receive EU-GMP Written Confirmation. Established in 2004, it manufactures and exports pharmaceuticals and APIs across 47 countries, with specialization in pellets, granules, tablets, capsules, and creams/ointments. The company holds EU-GMP, TGA, ANVISA, WHO-GMP, MFDS, and other international approvals.

Tosca Pharmachem (Tosco Pharmachem Pvt Ltd)

India

Tosco Pharmachem Pvt Ltd is an Indian pharmaceutical contract manufacturing company providing third-party/contract manufacturing services for formulated pharmaceutical products. The company's website has been compromised by spam, but search results confirm it operates as a CMO offering pharmaceutical manufacturing across multiple dosage forms including tablets, capsules, liquids, and topicals.

Trident Lifeline Limited

India

Trident Lifeline Limited is an Indian pharmaceutical company established in 2014, engaged in manufacturing and marketing finished dosage forms. The company offers contract manufacturing services (hybrid model: own products + third-party manufacturing) for tablets, capsules, dry powder, liquid, ointment, gel, and injectable products. WHO-GMP compliant with global presence in 40+ countries. 3133+ products registered with India FDA, 989+ globally registered products.

Valpharma Group

San Marino

Valpharma Group is a pharmaceutical and nutraceutical CDMO based in San Marino with 40+ years of experience. The group consists of Valpharma San Marino S.p.A. and Valpharma International S.p.A. (two CDMO pharmaceutical companies) plus Erba Vita Group S.p.A. (nutraceuticals). They specialize in modified-release products in capsules and tablets, including narcotic and psychotropic substances. Services include contract manufacturing, tech transfer, regulatory and e-CTD management, pharmaceutical development, stability studies, and IMP (investigational medicinal product) batch production. They operate three production plants and are routinely audited by Italian Health Authorities for GMP compliance. Products sold in 70+ countries.

Vefa İlaç San. ve Tic. A.Ş.

Turkey

Vefa Ilac San. ve Tic. A.S. is a Turkish pharmaceutical manufacturer based in Beylikduzu, Istanbul, established in 2012 with GMP certification obtained in 2013. They manufacture pharmaceuticals, traditional herbal medicines, food supplements, and personal care products for both domestic and export markets. They have significant production capacity: 902 million tablets/year, 270 million capsules/year, 252 million coated units/year, 48 million bottles/year, and 15 million cream & gel units/year. Products are exported to Azerbaijan, Georgia, Ukraine, Iraq, Yemen, Saudi Arabia, and Romania. They hold WHO GMP and ISO 9001:2015 certifications. Their vision focuses on becoming a leading private label (contract) production base in Eurasia for pharmaceutical and nutraceutical products.

Vianex S.A.

Greece

Vianex S.A. is a prominent Greek pharmaceutical company listed on PharmaSource as a CDMO. The company is described as specializing in contract development and manufacturing. While the website content is primarily in Greek and could not be fully parsed, PharmaSource confirms CDMO services. The company appears to have multiple manufacturing facilities (Factory A, B, C, D mentioned in navigation) and covers a broad range of dosage forms. Founded by Paul J. Giannacopoulos.

West Coast Pharmaceutical Works Ltd

India

West Coast Pharmaceutical Works Ltd is an Indian manufacturer of pharmaceutical formulations primarily for human and veterinary use. The company also produces nutraceutical products. West Coast is FDA-registered and operates contract manufacturing services for pharmaceutical formulations.

Wiewelhove

Germany

Wiewelhove GmbH is a German contract manufacturer specializing exclusively in solid dosage forms. The company provides galenic development, wet granulation, compaction, blending, tabletting, capsule filling, film coating, sugar coating, bottling, blistering, and packaging services. Wiewelhove positions itself as a reliable partner for all aspects of contract manufacturing of solid dosage forms.

Xedev

Belgium

Xedev is a flexible CDMO based in Belgium, specialized in formulation and process development for oral solid dosage forms. They offer early-phase development services including spray drying, hot melt extrusion, amorphous solid dispersions, and GMP clinical manufacturing for Phase I and Phase II batches.

Zile Bonbons (Zile Ltd.)

Switzerland

Zile Bonbons AG is a Swiss specialist contract manufacturer of lozenges, chews, and dragees for the pharmaceutical (OTC), nutraceutical, dietary supplement, and confectionery industries. Headquartered in Rupperswil, Switzerland, they have a dedicated OTC lozenges manufacturing plant. They provide full-service contract development and manufacturing from product conception through commercial production, including formulation development, prototyping, sourcing, manufacture, packaging, and logistics. Their technologies include stamping, cutting, moulding, and coating, with primary packaging options (wrapper/flow pack, bags, flip-top boxes, bars, blisters). They manufacture alternative drug delivery systems as centre-filled OTC lozenges with precise API dosage. They have pharmaceutical GMP expertise and are FDA-registered (FEI 3003236010) with 1 FDA inspection (VAI). Classified as CMO rather than CDMO because their development work is focused on lozenge formulation for third parties, but they do not position themselves as offering full drug development services beyond the lozenge/chew format.

ABC Farmaceutici, an ICE Pharma company, is an Italian CDMO established in 1925 specializing in oral solid and liquid formulation manufacturing. Their 76,000 sqm facility in Ivrea (near Turin) is fully GMP certified and regularly inspected by AIFA and FDA. As part of ICE Pharma, they manage the entire drug supply chain from API through finished dosage form manufacturing.

Contract Packaging Resources is a member of the Aenova Group, a worldwide leading CDMO for the pharmaceutical and healthcare industry. The Aenova Group provides comprehensive pharmaceutical manufacturing including solid dosage forms, sterile fill and finish, semi-solids, non-sterile liquids, softgels, gummies, and packaging services. The Latina site in Italy serves as the central sterile manufacturing facility with capacity for over 100 million units per year, handling biologics including monoclonal antibodies, peptides, and vaccines with isolator technology.